Spinal Tech

SANUWAVE reported revenues of $238,540 and net loss of $1.8 million during the first quarter of 2012.

The Food and Drug Administration granted 14 spine device-related clearances in April, according to an FDA report.

Regentis Biomaterials, a company focused on developing proprietary hydrogels for tissue regeneration, has raised $10 million in its latest round of funding from new investors Royal DSM through its venturing subsidiary, Crossroad Fund, Medica Venture Partners, SCPVitalife and Technion Investment…

SurgLine International has formed SurgLine MDC Holdings, a Delaware Limited Liability Corporation, as a wholly owned subsidiary.

MiMedx Group has reported first quarter net sales at $3.7 million, with net loss at $1 million.

Internal Fixation Systems has entered into a distribution agreement with Intelligent Orthopaedics to market its Staffordshire Orthopaedic Reduction Machine, a reusable device that is used to align fractures of the tibia prior to fixation.

The spinal implant market in the United States is expected to reach $7 billion by 2018, according to a report from iData Research.

The United States biomaterials market shows significant potential for growth in the future, according to a report from iData research.

BioMimetic Therapeutics, a Franklin, Tenn.-based medical device company, reported a net loss of $6.1 million during the first quarter of 2012.

TranS1, a Wilmington, N.C.-based spine device company, reported a 26 percent decrease in revenue for the first quarter of 2012.